Thomas Nichols is the CEO and Founder of Pretika MedTech Corporation.
Pretika is a medical device innovator leveraging advanced technologies under two divisions – Pretika® for consumer OTC aesthetics devices, and Pretika MedTech for connected wound care technology – a non-invasive, embedded within dressings device + wireless digital health technology to provide imaging, sensor and data analytics for Physicians and Nursing teams to monitor post-surgery, wound and disease healing remotely or in-person without having to remove the surgical dressings, bandages, wraps or casts. Each division is focused on our patented “connected AI” technology in the United States and other jurisdictions throughout the world.
Thom has assembled a global team of talent with proven expertise in product technology development, firmware/hardware, UX/UI, programming, intellectual property, smart healthcare cloud technology, FDA compliance large-scale component integration, manufacturing, marketing, sales, communications, finance, and international operations. With a focus on strategically building and managing strong consumer and medical devices combined with technology solutions for fast and effective brand management and growth.
In his role, Thom is responsible for all aspects of the business including overseeing strategic direction, financial performance, brand growth, company culture and the adherence to mission and values, intellectual property, product initiatives including asset and business acquisitions.
Thom is a proven marketing and general management leader with more than 20 years of experience in developing technology driven intellectual property, building brands, creating and delivering strategic growth plans, and developing strong and impactful teams. He earned an MBA from the Graziadio Business School, Pepperdine University, and a Bachelor of Business Administration in Marketing from The Shidler College of Business, University of Hawaii.
Pretika is a registered FDA Medical Device establishment.
Connected Wound Care Technology
Friday, April 12, 2024
10:40 AM - 10:45 AM EDT